Literature DB >> 9545320

Identification of a novel type of alternatively spliced exon from the acetylcholinesterase gene of Bungarus fasciatus. Molecular forms of acetylcholinesterase in the snake liver and muscle.

X Cousin1, S Bon, J Massoulié, C Bon.   

Abstract

The venom of the snake Bungarus fasciatus contains a hydrophilic, monomeric species of acetylcholinesterase (AChE), characterized by a C-terminal region that does not resemble the alternative T- or H-peptides. Here, we show that the snake contains a single gene for AChE, possessing a novel alternative exon (S) that encodes the C-terminal region of the venom enzyme, located downstream of the T exon. Alternative splicing generates S mRNA in the venom gland and S and T mRNAs in muscle and liver. We found no evidence for the presence of an H exon between the last common "catalytic" exon and the T exon, where H exons are located in Torpedo and in mammals. Moreover, COS cells that were transfected with AChE expression vectors containing the T exon with or without the preceding genomic region produced exclusively AChET subunits. In the snake tissues, we could not detect any glycophosphatidylinositol-anchored AChE form that would have derived from H subunits. In the liver, the cholinesterase activity comprises both AChE and butyrylcholinesterase components; butyrylcholinesterase corresponds essentially to nonamphiphilic tetramers and AChE to nonamphiphilic monomers (G1na). In muscle, AChE is largely predominant: it consists of globular forms (G1a and G4a) and trace amounts of asymmetric forms (A8 and A12), which derive from AChET subunits. Thus, the Bungarus AChE gene possesses alternatively spliced T and S exons but no H exon; the absence of an H exon may be a common feature of AChE genes in reptiles and birds.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545320     DOI: 10.1074/jbc.273.16.9812

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Potassium channel modulation by a toxin domain in matrix metalloprotease 23.

Authors:  Srikant Rangaraju; Keith K Khoo; Zhi-Ping Feng; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; Cory Pham; Peter Calabresi; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

2.  Diversity of metalloproteinases in Bothrops neuwiedi snake venom transcripts: evidences for recombination between different classes of SVMPs.

Authors:  Ana M Moura-da-Silva; Maria Stella Furlan; Maria Cristina Caporrino; Kathleen F Grego; José Antonio Portes-Junior; Patrícia B Clissa; Richard H Valente; Geraldo S Magalhães
Journal:  BMC Genet       Date:  2011-11-01       Impact factor: 2.797

Review 3.  Snake Genome Sequencing: Results and Future Prospects.

Authors:  Harald M I Kerkkamp; R Manjunatha Kini; Alexey S Pospelov; Freek J Vonk; Christiaan V Henkel; Michael K Richardson
Journal:  Toxins (Basel)       Date:  2016-12-01       Impact factor: 4.546

Review 4.  Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise.

Authors:  Julien Slagboom; Jeroen Kool; Robert A Harrison; Nicholas R Casewell
Journal:  Br J Haematol       Date:  2017-02-24       Impact factor: 6.998

5.  Toxinology provides multidirectional and multidimensional opportunities: A personal perspective.

Authors:  R Manjunatha Kini
Journal:  Toxicon X       Date:  2020-05-11

6.  Alternative mRNA Splicing in Three Venom Families Underlying a Possible Production of Divergent Venom Proteins of the Habu Snake, Protobothrops flavoviridis.

Authors:  Tomohisa Ogawa; Naoko Oda-Ueda; Kanako Hisata; Hitomi Nakamura; Takahito Chijiwa; Shousaku Hattori; Akiko Isomoto; Haruki Yugeta; Shinichi Yamasaki; Yasuyuki Fukumaki; Motonori Ohno; Noriyuki Satoh; Hiroki Shibata
Journal:  Toxins (Basel)       Date:  2019-10-09       Impact factor: 4.546

Review 7.  Tracing monotreme venom evolution in the genomics era.

Authors:  Camilla M Whittington; Katherine Belov
Journal:  Toxins (Basel)       Date:  2014-04-02       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.